Product Information
TRIPLE ANTIBIOTIC OINTMENT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.1248 per GM under NDC 45802014301. Its NADAC has been published 608 times since Feb 11, 2015.
Strength
400; 3.5; 5000 [USP'U]/g; mg/g; [USP'U]/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802014301
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M004On Market Since
5/20/2014
Pharmacological Classes
Price Statistics
The NADAC for TRIPLE ANTIBIOTIC OINTMENT has been published 608 times since Feb 11, 2015, and over the history we have for it it has risen 5.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1248 per GM |
|---|---|
| All-time high | $0.1829 (Apr 10, 2019) |
| All-time low | $0.1055 (Aug 17, 2022) |
| 52-week high | $0.1248 |
| 52-week low | $0.1190 |
| Median price | $0.1301 |
| Average price | $0.1351 |
| Largest weekly change | +45.1% (May 17, 2023) |
| Weeks tracked | 608 |
| Tracking since | Feb 11, 2015 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
bacitracin zinc, neomycin, polymyxin B market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIPLE ANTIBIOTIC OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for TRIPLE ANTIBIOTIC OINTMENT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.1248 per GM (NDC 45802014301), effective Sep 30, 2026.
How has the price of TRIPLE ANTIBIOTIC OINTMENT changed over time?
Over the history we have for it, the NADAC for TRIPLE ANTIBIOTIC OINTMENT has risen 5.5%. It has been tracked across 608 weekly CMS publications since Feb 11, 2015.
What are the highest and lowest recorded NADAC prices for TRIPLE ANTIBIOTIC OINTMENT?
Since Feb 11, 2015, the NADAC for TRIPLE ANTIBIOTIC OINTMENT has ranged from a low of $0.1055 (Aug 17, 2022) to a high of $0.1829 (Apr 10, 2019), with a median of $0.1301 per GM.
Are there cheaper alternatives to TRIPLE ANTIBIOTIC OINTMENT?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GS FIRST AID ANTIBIOTIC OINT, is $0.0888 per GM — about 29% below TRIPLE ANTIBIOTIC OINTMENT.
Who manufactures TRIPLE ANTIBIOTIC OINTMENT?
TRIPLE ANTIBIOTIC OINTMENT (NDC 45802014301) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.